Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy

Por Felton, T. W., Roberts, J. A., Lodise, T. P., Van Guilder, M., Boselli, E., Neely, M. N., Hope, W. W.
Publicado em 2014

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

Por Felton, T W, McCalman, K, Malagon, I, Isalska, B, Whalley, S, Goodwin, J, Bentley, A M, Hope, W W
Publicado em 2014

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Por Felton, T. W., Hope, W. W., Lomaestro, B. M., Butterfield, J. M., Kwa, A. L., Drusano, G. L., Lodise, T. P.
Publicado em 2012

Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Thr...

Por Livermore, J. L., Felton, T. W., Abbott, J., Sharp, A., Goodwin, J., Gregson, L., Warn, P. A., Howard, S. J., Hope, W. W.
Publicado em 2013

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa

Por Felton, T. W., Goodwin, J., O'Connor, L., Sharp, A., Gregson, L., Livermore, J., Howard, S. J., Neely, M. N., Hope, W. W.
Publicado em 2013

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children

Por Ramos-Martín, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., Paulus, S., López-Herce, J., Hope, W. W.
Publicado no Antimicrob Agents Chemother (2017)

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

Por Ramos-Martín, V., Neely, M. N., McGowan, P., Siner, S., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., Paulus, S., Hope, W. W.
Publicado no J Antimicrob Chemother (2016)

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

Por Slater, J. L., Howard, S. J., Sharp, A., Goodwin, J., Gregson, L. M., Alastruey-Izquierdo, A., Arendrup, M. C., Warn, P. A., Perlin, D. S., Hope, W. W.
Publicado em 2011

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

Por Ramos-Martín, V., Johnson, A., Livermore, J., McEntee, L., Goodwin, J., Whalley, S., Docobo-Pérez, F., Felton, T. W., Zhao, W., Jacqz-Aigrain, E., Sharland, M., Turner, M. A., Hope, W. W.
Publicado no J Antimicrob Chemother (2016)

Population Pharmacokinetics of Teicoplanin in Children

Por Ramos-Martín, V., Paulus, S., Siner, S., Scott, E., Padmore, K., Newland, P., Drew, R. J., Felton, T. W., Docobo-Pérez, F., Pizer, B., Pea, F., Peak, M., Turner, M. A., Beresford, M. W., Hope, W. W.
Publicado no Antimicrob Agents Chemother (2014)

Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance

Por Docobo-Pérez, F., Drusano, G. L., Johnson, A., Goodwin, J., Whalley, S., Ramos-Martín, V., Ballestero-Tellez, M., Rodriguez-Martinez, J. M., Conejo, M. C., van Guilder, M., Rodríguez-Baño, J., Pascual, A., Hope, W. W.
Publicado no Antimicrob Agents Chemother (2015)